Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
Top Cited Papers
- 31 January 2005
- journal article
- clinical trial
- Published by Elsevier BV in Biological Psychiatry
- Vol. 57 (6), 594-608
- https://doi.org/10.1016/j.biopsych.2004.12.006
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- SHORT COMMUNICATION Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoidsEuropean Journal of Neuroscience, 2002
- Endocannabinoids in cognition and dependenceProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- The neurobiology and evolution of cannabinoid signallingPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- High Resolution Brain SPECT Imaging of Marijuana Smokers with AD/HDJournal of Psychoactive Drugs, 1998
- Δ9-Tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brainEuropean Journal of Neuroscience, 1998
- Roles of dopamine D1 receptors inΔ9-tetrahydrocannabinol-induced expression of Fos protein in the rat brainBrain Research, 1996
- Anxiolytic effect of cannabidiol derivatives in the elevated plus-mazeGeneral Pharmacology: The Vascular System, 1994
- Long-term retention of implicit learning in Huntington's diseaseNeuropsychologia, 1991
- The hopkins verbal learning test: Development of a new memory test with six equivalent formsThe Clinical Neuropsychologist, 1991
- Changes in brain dopaminergic indices induced by perinatal exposure to cannabinoids in ratsDevelopmental Brain Research, 1990